S4 Fig - by Laila Aboulatta (11531371)

Subjects:

S2 Fig - by Laila Aboulatta (11531371)

Subjects:

Fig 3 - by Laila Aboulatta (11531371)

Subjects:

Logistic regression model of mortality in septic (qSOFA≥1) patients without malaria: 2012–2019 (N = 5,323). by Brian Rice (4393609)

Subjects:

S1 Data - by Eszter Nagy (398278)

Subjects:

Increased temperature decreases the duration of YFV RNA positivity when extracted from FTA cards. by Emily H. Davis (12878086)

S1 Database - by Dávid Garbaisz (5657449)

Database glaucoma (1). by Carlo Catti (22530186)

Myelinopathy results in a significantly reduced spike probability and increased latency after a release event. by Maral Budak (6680351)

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. by Hala Tamim El Jarkass (16625309)

Subjects:

Characteristics of non-septic (qSOFA = 0) and septic (qSOFA≥1) emergency unit patients with suspected infections (N = 17,490). by Brian Rice (4393609)

Subjects:

S1 Database - by Hassan Tarhini (17102751)

CR decreases mtDNA copy number in MLH1 deficient cells. by Berna Somuncu (12770334)

S1 Database - by Gihan Shu (12060407)

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed... by Jelena Filimonovic (22305307)

Subjects:

Full database. by M. d’Ussel (12476036)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Migraine burden and costs in France: a nationwide claims database analysis of triptan users by Anne Donnet (6426176)

“…</p> <p><b>Methods:</b> A cross-sectional retrospective analysis was performed on the Echantillon Généraliste des Bénéficiaires claims database, a 1/97 random sample of the French public insurance database. …”

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)